<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03340649</url>
  </required_header>
  <id_info>
    <org_study_id>2017ZDSYLL095-P01</org_study_id>
    <nct_id>NCT03340649</nct_id>
  </id_info>
  <brief_title>The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis</brief_title>
  <official_title>The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Evaluating Sepsis Patient's Disease Severity and Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jingyuan,Xu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the changes of plasma hepatocyte growth factor and soluble receptor s-Met levels
      in patients with sepsis, and to explore its clinical significance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 patients who diagnosed as sepsis were included in this study. Then keep blood samples from
      these patients in the first day, the third day, detect the hepatocyte growth factor and
      soluble receptor s-Met level in plasma byenzyme-linked immuno sorbent assay. Record Severity
      of illness and survival status of every patient within 28 days. Objective to evaluate the
      correlation between the level of hepatocyte growth factor and soluble receptor s-Met in
      plasma and the prognosis of the patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 9, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 9, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>28-day</time_frame>
    <description>28-day mortality</description>
  </primary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Sepsis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>taking peripheral blood</intervention_name>
    <description>taking peripheral blood of no more than 3ml</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        sepsis patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients admitted to ICU diagnosed of sepsis(sepsis3.0 criteria)

          2. Patients signing informed consent

        Exclusion Criteria:

          1. Age is less than 18 years old or more than 80 years old

          2. Pregnant women

          3. Patients with tumor、hepatitis、liver cirrhosis、acute myocardial infarction、chronic
             renal tubular nephritis、interstitial pneumonia、acute pancreatitis、systemic lupus
             erythenatosus、ulcerative colitis、crohn's disease、HELLP syndrome

          4. Prothrombin time is extension in patients with after liver transplantation

          5. Patients with chronic renal failure

          6. Patients after kidney transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yi yang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongda Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>chenglong liang, master</last_name>
    <phone>15261893562</phone>
    <email>15261893562@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>yi yang, doctor</last_name>
    <phone>+8602583262550</phone>
    <email>yiyiyang2004@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>chenglong liang, master</last_name>
      <phone>15261893562</phone>
      <email>15261893562@163.com</email>
    </contact>
    <contact_backup>
      <last_name>yi yang, doctor</last_name>
      <phone>+8602583262550</phone>
      <email>yiyiyang2004@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2017</study_first_submitted>
  <study_first_submitted_qc>November 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>November 9, 2017</last_update_submitted>
  <last_update_submitted_qc>November 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jingyuan,Xu</investigator_full_name>
    <investigator_title>Attending doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no share IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

